RXFP1 mediated the motility-enhancing effect of RLN2 via induction of S100A4 in human thyroid carcinoma cells and RLN2 enhanced thyroid xenograft angiogenesis (14). The gene discussed is RLN2; the disease is thyroid gland carcinoma.